Article Text

This article has a correction. Please see:

Download PDFPDF
Review: mood stabilisers monotherapy as effective as combination therapy for treatment of acute bipolar depression in studies with some limitations

Statistics from


  • Sources of funding Not stated.


  • Competing interests RHP has received consulting fees or honoraria from AstraZeneca, Bristol Myers-Squibb, Pfizer, Eli Lilly and Co, Glaxo SmithKline, Proteus Biomedical and Concordant Rater Systems. RHP receives royalties and holds equity in Concordant Rater Systems.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles